
News|Articles|April 7, 2014
Dalton Pharma Completes Aseptic Filling Capabilities Expansion
Author(s)Pharmaceutical Technology Editors
Dalton Pharma completes its $2.5 million expansion in Toronto for sterile and aseptic filling capabilities.
Advertisement
Dalton Pharma Services
, a privately owned pharmaceutical services provider, reported the completion of a $2.5 million expansion of its sterile and aseptic filling capabilities in Toronto, Canada. This project included addition ofsterile vial processing and washing, expanded vial depyrogenation capability, automated vial inspection capability, a new Water For Injection (WFI) system, and expanded and improved gowning areas for GMP manufacturing operators.
Source:
Dalton Pharma Services
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
3
Investigating Patient Complaints About Combination Products
4
CPHI Americas: The Business Case for Product Carbon Footprints in Pharma
5




